Ecog Multiple Myeloma Equate Trial (Eaa181)
Posted Date: Apr 20, 2021
- Investigator: Bryan Hambley
- Type of Study: Drug
A randomized, phase 3 trial for newly diagnosed multiple myeloma comparing induction regimens in patients not planned for early autologous transplant.
Criteria:
Newly Diagnosed Adults With Multiple Myeloma.
Keywords:
Myeloma, Daratumumab, Mrd
For More Information:
Bryan Hambley
5138544268
hamblebc@ucmail.uc.edu